… the region, spanning active pharmaceutical ingredients (APIs), formulations, … of shifting regulated pharmaceutical manufacturing, Piramal expects … looking like for the second half? Piramal: We have … quarter and indicated flat revenue growth, with margins …

… contributes 2% to group revenue of R132.4bn, continues … medicine sales. Health business revenue for the 52 weeks … second half of the 2026 financial year.” Aptekor Group is a pharmaceutical … created an immediate convenience revenue without adding complexities to …

… gained renewed traction over the second half of this year, with buyers … segments with regulatory complexity contracted revenue, and expansion potential, with … growth and pricing power—citing pharmaceutical and healthcare logistics, dedicated transport …

… outliers being those in the pharmaceutical and consumer industries, according … in some cases towards the second half of the calendar year. … a potential impact on profit and loss, as liabilities … similar to last year. The pharma, consumer, consulting industry is …

… significant angiokeratomas in the second half of 2026 Angiokeratomas are … the FDA and a drug company is encouraged throughout the … study initiation expected in the second half of 2026. About Palvella … that may be more profitable or successful than Palvella’ …

… to be operational by the second half of 2028. A technology partner … services, consumer goods & retail, pharmaceuticals, hospitals, industrials, media & … improving operational efficiency (47%), boosting revenue generation (21%) and reducing headcount …

… results and visibility into the second half of the year, we … of deep biological data, pharmacology capabilities and our PDX … . As we enter the second half of the fiscal year, … reflected meaningful progress across both revenue and margin performance, supported …

… for opening in the second half and are actively advancing … prior-year quarter.  Gross profit. Gross profit of $5.9 million … DAVIDsTEA entered into a revenue-linked financing agreement under which … 4,000 grocery stores and pharmacies, over 1,500 convenience …

… enter the market in the second half of 2026 following expedited regulatory … forecasting $3 billion in Orfoglipron revenue in 2026, far above consensus … the next phase of the pharma giant. BofA’s Gerberry sees …

… businesses are consolidating to generate profitability and that’s why you … was a recovery in the second half so 2025 is more or … popularity of the weight-loss pharmaceuticals that are going to affect …